ACHE and early-onset autosomal dominant Alzheimer disease: Up to today, acetylcholinesterase inhibitors represent the major approved drugs to treat Alzheimer’s disease, and therefore, many efforts have been devoted to the identification of novel compounds able to inhibit AChE as potential drugs for the treatment of this neurodegenerative disease [30,31].